BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Z, Yu W, Chen S, Chen Y, Chen L, Zhang S. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma. Oncol Rep 2018;40:49-60. [PMID: 29749528 DOI: 10.3892/or.2018.6411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Danilova NV, Anikina KA, Oleynikova NA, Vychuzhanin DV, Malkov PG. [Claudin-3 expression in gastric cancer]. Arkh Patol 2020;82:5-11. [PMID: 32307433 DOI: 10.17116/patol2020820215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Hashimoto I, Oshima T. Claudins and Gastric Cancer: An Overview. Cancers (Basel) 2022;14:290. [PMID: 35053454 DOI: 10.3390/cancers14020290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
3 Fang WL, Chen MH, Huang KH, Chang SC, Lin CH, Chao Y, Lo SS, Li AF, Wu CW, Shyr YM. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array. Clin Epigenetics 2019;11:154. [PMID: 31675985 DOI: 10.1186/s13148-019-0747-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Ren F, Zhao Q, Zhao M, Zhu S, Liu B, Bukhari I, Zhang K, Wu W, Fu Y, Yu Y, Tang Y, Zheng P, Mi Y. Immune infiltration profiling in gastric cancer and their clinical implications. Cancer Sci 2021;112:3569-84. [PMID: 34251747 DOI: 10.1111/cas.15057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]